| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |